Ionis Pharmaceuticals (IONS) Cash from Operations (2009 - 2026)

Ionis Pharmaceuticals' Cash from Operations history runs 18 years deep, the most recent figure standing at 792819000.0 for Q1 2026.

• On a quarterly basis, Cash from Operations fell 425.83% year-over-year to 792819000.0 in Q1 2026; TTM through Mar 2026 was 910627000.0, a 81.48% decrease from a year earlier, with the FY2025 full-year figure at 268583000.0, up 46.38% from the prior year.
• Cash from Operations declined to 792819000.0 in Q1 2026 per IONS's latest filing, from 137709000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 151338000.0 in Q2 2025 and bottomed at 792819000.0 in Q1 2026.
• The 5-year median for Cash from Operations is 116139000.0 (2024), against an average of 126131294.12.
• Across the five-year window, Cash from Operations slumped 453.38% in 2024 and jumped 226.24% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 200195000.0 in 2022, then soared by 116.42% to 32865000.0 in 2023, then slumped by 453.38% to 116139000.0 in 2024, then retreated by 18.57% to 137709000.0 in 2025, then plunged by 475.72% to 792819000.0 in 2026.
• Per Business Quant, the three latest IONS Cash from Operations figures stand at 792819000.0 (Q1 2026), 137709000.0 (Q4 2025), and 131437000.0 (Q3 2025).